Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Shimada

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
JAMA Network Open|May 18, 2019
Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in JapanToyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, et al.
Traffic (Copenhagen, Denmark)|October 10, 2013
Simple and direct assembly of kymographs from movies using KYMOMAKERKyoko Chiba, Yuki Shimada, Masataka Kinjo, et al.
Bioethics|June 17, 2021
Accuracy of post-publication Financial Conflict of Interest corrections in medical research: A secondary analysis of pharmaceutical company payments to the authors of the CREATE-X trial report in the New England Journal of MedicineAkihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016Yuki Shimada, Akihiko Ozaki, Hiroaki Saito, et al.
International Journal of Health Policy and Management|October 4, 2016
Defining and Acting on Global Health: The Case of Japan and the Refugee CrisisClaire Leppold, Akihiko Ozaki, Yuki Shimada, et al.
Clinical Pharmacology and Therapeutics|May 19, 2020
Pharmaceutical Company Payments to Japanese Government Drug Regulation Committee MembersToyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, et al.
JAMA Network Open|April 27, 2019
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in JapanHiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, et al.
BMC Public Health|June 19, 2026
Association between late afternoon and early evening physical activity and next-day depression and anxiety symptoms among workers in Japan: a two-week longitudinal studyYuki Shimada, Kazuhiro Watanabe, Hiroyuki Hikichi, et al.
ACS Applied Materials & Interfaces|January 20, 2026
Dual-Pathway CO Sensing Mechanism in Pd-Loaded SnO<sub>2</sub> Nanocrystals: An Operando Spectroscopic StudySoki Yoneda, Yuki Shimada, Muhammad Sohail Ahmad, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 11, 2020
Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatmentFuta Kida, Anju Murayama, Hiroaki Saito, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
JAMA Network Open|May 18, 2019
Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in JapanToyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, et al.
Traffic (Copenhagen, Denmark)|October 10, 2013
Simple and direct assembly of kymographs from movies using KYMOMAKERKyoko Chiba, Yuki Shimada, Masataka Kinjo, et al.
Bioethics|June 17, 2021
Accuracy of post-publication Financial Conflict of Interest corrections in medical research: A secondary analysis of pharmaceutical company payments to the authors of the CREATE-X trial report in the New England Journal of MedicineAkihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016Yuki Shimada, Akihiko Ozaki, Hiroaki Saito, et al.
International Journal of Health Policy and Management|October 4, 2016
Defining and Acting on Global Health: The Case of Japan and the Refugee CrisisClaire Leppold, Akihiko Ozaki, Yuki Shimada, et al.
Clinical Pharmacology and Therapeutics|May 19, 2020
Pharmaceutical Company Payments to Japanese Government Drug Regulation Committee MembersToyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, et al.
JAMA Network Open|April 27, 2019
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in JapanHiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, et al.
BMC Public Health|June 19, 2026
Association between late afternoon and early evening physical activity and next-day depression and anxiety symptoms among workers in Japan: a two-week longitudinal studyYuki Shimada, Kazuhiro Watanabe, Hiroyuki Hikichi, et al.
ACS Applied Materials & Interfaces|January 20, 2026
Dual-Pathway CO Sensing Mechanism in Pd-Loaded SnO<sub>2</sub> Nanocrystals: An Operando Spectroscopic StudySoki Yoneda, Yuki Shimada, Muhammad Sohail Ahmad, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 11, 2020
Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatmentFuta Kida, Anju Murayama, Hiroaki Saito, et al.
Pageof 8